Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.43 | 40.9523809524 | 1.05 | 1.63 | 1.04 | 8929412 | 1.36904359 | CS |
| 4 | 0.39 | 35.7798165138 | 1.09 | 1.63 | 0.8746 | 3971297 | 1.25443685 | CS |
| 12 | 0.26 | 21.3114754098 | 1.22 | 1.63 | 0.772 | 2187099 | 1.1742834 | CS |
| 26 | 0.38 | 34.5454545455 | 1.1 | 1.63 | 0.772 | 1267869 | 1.18766216 | CS |
| 52 | 0.8995 | 154.952627046 | 0.5805 | 1.72 | 0.5612 | 1273510 | 1.20456479 | CS |
| 156 | -3.6 | -70.8661417323 | 5.08 | 7.4 | 0.4986 | 664602 | 1.45299309 | CS |
| 260 | -1.3 | -46.7625899281 | 2.78 | 19.38 | 0.4986 | 769393 | 5.89225772 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
